Pathogenetic therapy in patients with COVID-19
The new coronavirus infection (COVID-19) has become a truly global challenge for all of humanity, and, above all, for the healthcare system. Among its most important aspects that require careful analysis are the clinical and laboratory features of the course of the disease, which make it possible to...
Saved in:
| Main Authors: | V. A. Kapatsina, M. A. Vashukova, D. A. Gusev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2022-10-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1394 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with the use of recombinant humanized monoclonal antibodies to the human receptor for interleukin-6 in patients with CoVID-19
by: D. А. Gusev, et al.
Published: (2020-08-01) -
The role of dendritic cells in COVID-19 infection
by: Xuying Wang, et al.
Published: (2023-12-01) -
Ageing and dysregulated lung immune responses in fatal COVID-19
by: Natália de Souza Xavier Costa, et al.
Published: (2025-07-01) -
Clinical-pathogenetic and prognostic value of the nitrotyrosine level in the blood serum of patients with coronavirus disease (COVID-19) with pneumonia
by: O. V. Riabokon, et al.
Published: (2024-08-01) -
Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic
by: V. N. Yakimets, et al.
Published: (2024-01-01)